301
|
|
|
Glutamate metabotropic receptor 3 |
GLUR3, GPRC1C, MGLUR3, mGlu3 |
|
302
|
|
|
Glutamate metabotropic receptor 4 |
GPRC1D, MGLUR4, mGlu4 |
|
303
|
|
|
Glutamate metabotropic receptor 5 |
GPRC1E, MGLUR5, PPP1R86, mGlu5 |
Asymmetric diabetic proximal motor neuropathy, Attention deficit hyperactivity disorder, Bipolar disorder, Diabetic amyotrophy, Diabetic asymmetric polyneuropathy, Diabetic autonomic neuropathy, Diabetic mononeuropathy, Diabetic nephropathy, Diabetic neuralgia, Diabetic polyneuropathy, Epilepsy, Grand mal status epilepticus, Mental depression, Minimal brain dysfunction, Narcolepsy, Nonconvulsive status epilepticus, Petit mal status, Schizophrenia, Status epilepticus, Symmetric diabetic proximal motor neuropathyView all (5 more) |
304
|
|
|
Glutamate metabotropic receptor 6 |
CSNB1B, GPRC1F, MGLUR6, mGlu6 |
Breast cancer, Congenital stationary night blindness, Disorder of eye, Hemeralopia, Hypoplasia of optic disc, Leber congenital amaurosis, Myopia, Night blindness, Nyctalopia, Nystagmus, Strabismus, Congenital stationary night blindness, x-linked |
305
|
|
|
Glutamate metabotropic receptor 7 |
GLUR7, GPRC1G, MGLU7, MGLUR7, NEDSHBA, PPP1R87 |
|
306
|
|
|
Glutamate metabotropic receptor 8 |
GLUR8, GPRC1H, MGLUR8, mGlu8 |
|
307
|
|
|
Gastrin releasing peptide |
BN, GRP-10, preproGRP, proGRP |
|
308
|
|
|
Gastrin releasing peptide receptor |
BB2, BB2R, BRS2 |
|
309
|
|
|
Glycogen synthase kinase 3 alpha |
- |
|
310
|
|
|
Glycogen synthase kinase 3 beta |
- |
Alzheimer disease, Bipolar disorder, Cognitive disorder, Congestive heart failure, Heart failure, Hypertension, Kidney failure, Malignant lymphoma, lymphocytic, intermediate differentiation, Lymphoma, lymphocytic, intermediate, Manic disorder, Melancholia, Mental depression, Mood disorder, Multiple congenital anomalies, Myocardial infarction, Neuronal ceroid lipofuscinosis, Peritonitis, Prostatic neoplasms, Prostate cancer, Acute kidney insufficiency, Schizophrenia, Senile dementia, TauopathiesView all (8 more) |